Company · INM
InMed Pharmaceuticals Inc.
Nasdaq's symbol directory lists INM on Nasdaq as “InMed Pharmaceuticals Inc. - Common Shares”.
In the 12 months to Nov 8, 2026: insiders bought on 22 occasions ($247K); 3 filings by holders of 5% or more; 4 company reports (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- ADAR1 Capital Management, LLC bought $205K
- Vivo Opportunity, LLC bought $42K
Every trade (22)
- BUYADAR1 Capital Management, LLC bought $5
- BUYADAR1 Capital Management, LLC bought $1K
- BUYADAR1 Capital Management, LLC bought $1
- BUYADAR1 Capital Management, LLC bought $1K
- BUYADAR1 Capital Management, LLC bought $11K
- BUYADAR1 Capital Management, LLC bought $750
- BUYADAR1 Capital Management, LLC bought $3K
- BUYADAR1 Capital Management, LLC bought $4K
- BUYADAR1 Capital Management, LLC bought $7K
- BUYADAR1 Capital Management, LLC bought $24K
- BUYADAR1 Capital Management, LLC bought $11K
- BUYADAR1 Capital Management, LLC bought $22K
- BUYADAR1 Capital Management, LLC bought $11K
- BUYADAR1 Capital Management, LLC bought $70K
- BUYADAR1 Capital Management, LLC bought $37K
- BUYVivo Opportunity, LLC bought $33
- BUYVivo Opportunity, LLC bought $23K
- BUYADAR1 Capital Management, LLC bought $2K
- BUYVivo Opportunity, LLC bought $8K
- BUYVivo Opportunity, LLC bought $2K
- BUYVivo Opportunity, LLC bought $7K
- BUYVivo Opportunity, LLC bought $924
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- ADAR1 Capital Management, LLC 17.2%
- Ikarian Capital, LLC 4.2%
- Vivo Opportunity Fund Holdings, L.P. 21.7%
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Amendments to articles or bylaws; change in fiscal year; Submission of matters to a vote of security holders; Other events Nov 5, 2026
- Regulation FD disclosure Nov 5, 2026
- Regulation FD disclosure Nov 3, 2026
- Notice of delisting or failure to meet a listing standard; Other events Sep 18, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.